External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial Fibrillation
Jiale Chen, Weikun Huang, Guoquan Chen, Bangbiao Ge, Qiang Zhao, Haiping Wang, Jiahao Ye, Jianing Pan, Kaili Mao · 2026
Read External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial Fibrillation by Jiale Chen, Weikun Huang, Guoquan Chen, Bangbiao Ge, Qiang Zhao, Haiping Wang, Jiahao Ye, Jianing Pan, Kaili Mao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13590000.txt.
Description
Jiale Chen and co-authors test, in 2026, whether published dosing models for a blood thinner work in older Chinese patients. The drug prevents strokes in people with an irregular heartbeat, and models exist to predict its levels in the body. Whether those models transfer to new patient groups was uncertain.
Six published models were checked against an independent group of one hundred thirty-five patients. None met the set accuracy standards, though one showed the least bias. Using a patient's own earlier measurements to update forecasts helped, but errors stayed sizable. The authors warn that imported dosing models need local testing before clinical use.
Catalog record
| CREATOR | Jiale Chen, Weikun Huang, Guoquan Chen, Bangbiao Ge, Qiang Zhao, Haiping Wang, Jiahao Ye, Jianing Pan, Kaili Mao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |